Molecular Therapy Oncolytics
Q1IF5.3SJR1.494
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2023 | 5.3 | Q1 | 78.6% | 1.494 | Q1 | 92.6% |
| 2022 | 5.7 | Q2 | 77.0% | 1.339 | Q1 | 91.5% |
| 2021 | 6.3 | Q2 | 76.5% | 1.530 | Q1 | 93.3% |
| 2020 | — | — | 1.424 | Q1 | 91.7% | |
| 2019 | — | — | 1.982 | Q1 | 95.6% | |
| 2018 | — | — | 1.753 | Q1 | 93.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2372-7705
region
Western Europe
coverage
2014-2023